Breaking News, Trials & Filings

Upperton Seeks MHRA Approval for New Sterile Manufacturing Facility

This submission follows the successful completion of aseptic process simulation validation batches executed under the requirements of the revised EU GMP Annex 1 requirements.

Author Image

By: Charlie Sternberg

Associate Editor

Upperton has submitted an application to the UK’s Medicines and Healthcare Products Regulatory Agency for approval of its new 7,000‑square‑foot sterile manufacturing facility in Nottingham. The filing follows completion of aseptic process simulation validation batches performed under the EU’s updated GMP Annex 1 standards. The site, built to current Eudralex Volume 4 Annex 1 requirements, expands Upperton’s footprint alongside its existing 50,000‑square‑foot development and manufacturing faci...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters